Catalyst Health Economics Consultants

Cerebral Palsy

1. Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.

Authors: FJ Ruiz, JF Guest, A Lehmann, AM Davie, K Güttler, O Schlüter & G Dreiss.
Source: European Journal of Health Economics 2004; 5(3): 227-235.

View Abstract


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2018